Xu H, Kaye JA, Saltus CW, Crawford J, Gasa E, Goodnough LT. Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents. Expert Rev Hematol. 2014 Oct;7(5):617-33. doi: 10.1586/17474086.2014.943730
Clarkson TB, Anthony MS. Effects of SERMs, tibolone, and soy isoflavones on cardiovascular risk factors and coronary artery atherosclerosis of surgically post-menopausal monkeys. J Menopausal Med. 2001;10(1):19-23.